TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW
PRESS RELEASES

Novus Therapeutics Appoints June Lee, M.D., To Board Of Directors

  • By Business Wire
  • Dec 9, 2020 8:30 AM EST
PRESS RELEASES

Novus Therapeutics Announces First Patient Enrolled In Phase 2a Clinical Trial Of Anti-CD40L Antibody AT-1501 In Amyotrophic Lateral Sclerosis

  • By Business Wire
  • Nov 2, 2020 8:00 AM EST
PRESS RELEASES

Novus Therapeutics Announces One-for-Eighteen Reverse Stock Split

  • By Business Wire
  • Oct 2, 2020 11:00 AM EDT
PRESS RELEASES

Novus Therapeutics Announces Acquisition Of Anelixis Therapeutics

  • By Business Wire
  • Sep 14, 2020 4:31 PM EDT
PRESS RELEASES

Novus Therapeutics Completes Enrollment Of Phase 2a Trial Of OP0201 In Pediatric Patients With Acute Otitis Media

  • By Business Wire
  • Mar 2, 2020 6:30 AM EST
PRESS RELEASES

Novus Therapeutics Announces Exercise Of Warrants For $4.7 Million Gross Proceeds

  • By Business Wire
  • Jan 10, 2020 5:19 PM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.